U.S. markets open in 8 hours 54 minutes
  • S&P Futures

    4,402.00
    +7.25 (+0.16%)
     
  • Dow Futures

    34,743.00
    +53.00 (+0.15%)
     
  • Nasdaq Futures

    15,092.25
    +18.75 (+0.12%)
     
  • Russell 2000 Futures

    2,197.80
    +6.10 (+0.28%)
     
  • Crude Oil

    68.40
    +0.25 (+0.37%)
     
  • Gold

    1,813.90
    -0.60 (-0.03%)
     
  • Silver

    25.44
    -0.02 (-0.06%)
     
  • EUR/USD

    1.1843
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    1.1840
    -1.1760 (-100.00%)
     
  • Vix

    17.97
    -18.04 (-100.00%)
     
  • GBP/USD

    1.3888
    +0.0003 (+0.02%)
     
  • USD/JPY

    109.6880
    +0.2200 (+0.20%)
     
  • BTC-USD

    39,376.61
    +1,449.22 (+3.82%)
     
  • CMC Crypto 200

    972.15
    +45.39 (+4.90%)
     
  • FTSE 100

    7,123.86
    +18.14 (+0.26%)
     
  • Nikkei 225

    27,711.19
    +127.11 (+0.46%)
     

ALERT: Halper Sadeh LLP Investigates CPAH, CBLI, QEP, SNCA; Shareholders Are Encouraged to Contact the Firm

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CounterPath Corporation (NASDAQ: CPAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Alianza, Inc. for $3.49 per share. If you are a CounterPath shareholder, click here to learn more about your rights and options.

Cleveland BioLabs, Inc. (NASDAQ: CBLI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Cytocom, Inc. Under the merger, Cleveland BioLabs stockholders are expected to own approximately 39% of the combined company. If you are a Cleveland BioLabs shareholder, click here to learn more about your rights and options.

QEP Resources, Inc. (NYSE: QEP) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Diamondback Energy, Inc. for 0.05 shares of Diamondback common stock for each share of QEP common stock. If you are a QEP shareholder, click here to learn more about your rights and options.

Seneca Biopharma, Inc. (NASDAQ: SNCA) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Leading BioSciences, Inc. If you are a Seneca shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com